It was reported that the procedure was to treat a 90% stenosed de novo lesion in the internal carotid artery with mild calcification and mild tortuosity.An embolic protection device (epd) was advanced to the it's intended location; then, the 7-10x30mm acculink self-expanding stent system (sess) was advanced to the target lesion.The position of the sess was confirmed and the hemostatic valve was opened.The physician began to deploy the stent; however, during deployment the stent shortened and jumped proximal to the target lesion and did not fully cover the lesion.The stent deployed partially in the lesion and partially in healthy tissue.Therefore, a 9-7x40mm xact stent was deployed to cover the lesion.Post-dilatation was performed followed by removal of the epd.There was no adverse patient effect and no clinically significant delay in the procedure.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.It is possible that the delivery system was slightly pushed distally as the stent was being deployed and/or interaction with the mildly calcified, mild torturous and 90% stenosed anatomy resulting in the reported stent shortened; then eventually the stent jumped in a spring like release resulting in the reported stent malposition; however, this could not be confirmed.The investigation determined a conclusive cause for the reported difficulties cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|